Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GTHP

Guided Therapeutics, Inc.

USD

Set alert

Price alert · GTHP

All alert types
0.15 USD +0.01 +3.45%
As of Oct 30, 2026
0.15 Day range 0.1501
0.132 52-week range 0.54
YTD
-72.22%
1 year
-44.44%
Open
0.15
Prev close
0.145
Mkt cap
14.48M
Vol
5.74K
Avg vol
26.54K
EPS
-0.04
P/E
0.00
More statistics
Low
0.15
High
0.1501

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GTHP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-197.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -12.6×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: 0.2×FY 2019: -0.6×FY 2020: -8.8×FY 2021: -3.2×FY 2022: -2.0×FY 2023: -2.1×FY 2024: -3.3×FY 2025: -12.6×
FY 2016 5y median -3.2× FY 2025
P/S 55.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.9×FY 2019: 32.3×FY 2020: 37.2×FY 2021: 95.8×FY 2022: 750×FY 2023: 80.1×FY 2024: 1229×FY 2025: 55.2×
FY 2016 5y median 95.8× FY 2025
P/B -7.1×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.3×FY 2021: -1.4×FY 2022: -3.4×FY 2023: -2.1×FY 2024: -1.8×FY 2025: -7.1×
FY 2016 5y median -2.1× FY 2025
P/FCF -39.6×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.1×FY 2019: -1.4×FY 2020: -2.0×FY 2021: -4.8×FY 2022: -6.5×FY 2023: -4.5×FY 2024: -7.7×FY 2025: -39.6×
FY 2016 5y median -6.5× FY 2025
EV/EBITDA -18.3×
FY 2016: -4.7×FY 2017: -0.5×FY 2018: 1.9×FY 2019: -12.9×FY 2020: 10.0×FY 2021: -12.0×FY 2022: -2.6×FY 2023: -3.0×FY 2024: -5.3×FY 2025: -18.3×
FY 2016 5y median -5.3× FY 2025
EV/Sales 59.0×
FY 2016: 6.6×FY 2017: 19.0×FY 2018: 92.3×FY 2019: 175×FY 2020: 78.6×FY 2021: 124×FY 2022: 746×FY 2023: 95.1×FY 2024: 1482×FY 2025: 59.0×
FY 2016 5y median 124× FY 2025
FCF Yield -2.5%
FY 2016: -611403.3%FY 2017: -29499.4%FY 2018: -838.1%FY 2019: -69.2%FY 2020: -49.4%FY 2021: -20.7%FY 2022: -15.5%FY 2023: -22.2%FY 2024: -13.0%FY 2025: -2.5%
FY 2016 5y median -15.5% FY 2025

Profitability

Gross Margin 74.4%
FY 2016: 18.5%FY 2017: -117.2%FY 2018: -56.1%FY 2019: -94.4%FY 2020: 140.2%FY 2021: 24.7%FY 2022: -523.1%FY 2023: 36.7%FY 2024: 28.6%FY 2025: 74.4%
FY 2016 5y median 28.6% FY 2025
Operating Margin -309.3%
FY 2016: -631.4%FY 2017: -1279.1%FY 2018: -2715.8%FY 2019: -2602.8%FY 2020: -1031.4%FY 2021: -2916.0%FY 2022: -25638.5%FY 2023: -3527.6%FY 2024: -30114.3%FY 2025: -309.3%
FY 2016 5y median -3527.6% FY 2025
Net Margin -416.7%
FY 2016: -656.2%FY 2017: -4383.6%FY 2018: 1782.5%FY 2019: -5336.1%FY 2020: -273.5%FY 2021: -2555.6%FY 2022: -33392.3%FY 2023: -3560.2%FY 2024: -34528.6%FY 2025: -416.7%
FY 2016 5y median -3560.2% FY 2025
ROE 53.2%
FY 2016: 42.8%FY 2017: 55.1%FY 2018: -6.4%FY 2019: 11.3%FY 2020: 2.6%FY 2021: 38.0%FY 2022: 150.6%FY 2023: 91.7%FY 2024: 49.4%FY 2025: 53.2%
FY 2016 5y median 53.2% FY 2025
ROIC 77.3%
FY 2016: 100.2%FY 2017: 49.7%FY 2018: 25.8%FY 2019: 16.1%FY 2020: 24.9%FY 2021: 96.5%FY 2022: 542.0%FY 2023: 197.8%FY 2024: 77.2%FY 2025: 77.3%
FY 2016 5y median 96.5% FY 2025
ROA -241.4%
FY 2016: -266.1%FY 2017: -2187.3%FY 2018: 430.5%FY 2019: -162.8%FY 2020: -20.7%FY 2021: -101.5%FY 2022: -129.0%FY 2023: -209.0%FY 2024: -175.4%FY 2025: -241.4%
FY 2016 5y median -175.4% FY 2025

Growth (YoY)

Revenue 10857.1%
FY 2016: -0.2%FY 2017: -59.7%FY 2018: -76.6%FY 2019: -36.8%FY 2020: 183.3%FY 2021: -20.6%FY 2022: -84.0%FY 2023: 653.8%FY 2024: -92.9%FY 2025: 10857.1%
FY 2016 FY 2025
Operating Income -12.5%
FY 2016: 38.7%FY 2017: 18.3%FY 2018: 50.4%FY 2019: 39.5%FY 2020: -12.3%FY 2021: -124.5%FY 2022: -41.1%FY 2023: -3.7%FY 2024: 39.0%FY 2025: -12.5%
FY 2016 FY 2025
EPS (diluted) 5.5%
FY 2016: 99.9%FY 2017: 79.0%FY 2018: 100.0%FY 2019: -4302.9%FY 2020: 93.1%FY 2021: -350.0%FY 2022: 16.7%FY 2023: 51.0%FY 2024: 38.5%FY 2025: 5.5%
FY 2016 FY 2025
Free Cash Flow 4.4%
FY 2016: 55.5%FY 2017: 36.5%FY 2018: -19.3%FY 2019: 41.0%FY 2020: -132.8%FY 2021: 14.4%FY 2022: 6.0%FY 2023: -15.7%FY 2024: 35.9%FY 2025: 4.4%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.3× FY 2025
Quick Ratio 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.5×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Debt / Equity -0.5×
FY 2016: -0.4×FY 2017: -0.2×FY 2018: -0.3×FY 2019: -0.4×FY 2020: -0.4×FY 2021: -0.5×FY 2022: -0.8×FY 2023: -0.5×FY 2024: -0.4×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
Net Debt / EBITDA -1.2×
FY 2016: -4.7×FY 2017: -0.5×FY 2018: 1.8×FY 2019: -10.5×FY 2020: 5.3×FY 2021: -2.7×FY 2022: 0.0×FY 2023: -0.5×FY 2024: -0.9×FY 2025: -1.2×
FY 2016 5y median -0.9× FY 2025
Interest Coverage -3.8×
FY 2016: -2.0×FY 2017: -2.8×FY 2018: -0.9×FY 2019: -0.7×FY 2020: -1.0×FY 2021: -2.1×FY 2022: -5.7×FY 2023: -12.4×FY 2024: -5.5×FY 2025: -3.8×
FY 2016 5y median -5.5× FY 2025

Dividends

Dividend Yield 0.4%
FY 2016: 347773.8%FY 2017: 0.0%FY 2018: 71.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 2.0%FY 2025: 0.4%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -4.7%
FY 2016: -25.8%FY 2017: 0.0%FY 2018: 11.4%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -7.2%FY 2025: -4.7%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31